| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-07 |